Loading…
Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome
To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS). Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100 mg/day CC administered daily from days...
Saved in:
Published in: | European journal of obstetrics & gynecology and reproductive biology 2006-06, Vol.126 (2), p.201-205 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953 |
container_end_page | 205 |
container_issue | 2 |
container_start_page | 201 |
container_title | European journal of obstetrics & gynecology and reproductive biology |
container_volume | 126 |
creator | Kurabayashi, Takumi Suzuki, Mina Fujita, Kazuyuki Murakawa, Haruo Hasegawa, Isao Tanaka, Kenichi |
description | To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS).
Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100
mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed.
For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120
min, the area under the curve (AUC) and blood insulin levels at 120
min in the non-responder group (
n
=
25) were significantly higher than those in the responder group (
n
=
34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120
mg/dl for the blood glucose level at 120
min and 9000 for the blood glucose
×
insulin level at 120
min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived (
n
=
9) and non-conceived groups (
n
=
21).
The levels of blood glucose and blood glucose
×
insulin at 120
min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study. |
doi_str_mv | 10.1016/j.ejogrb.2005.11.005 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68017600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030121150500610X</els_id><sourcerecordid>68017600</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</originalsourceid><addsrcrecordid>eNp9kE1P4zAYhK0VKyhd_sEK-QK3ZP3Gie1ckBDiS0KCw-51Ldd5U1wlcbDTov57XFqJG76MLD0zHg8hv4HlwED8WeW48suwyAvGqhwgT_KDzEDJIpOiKo_IjHEGWQFQnZDTGFcsHc7rY3ICgnMpCzUj_1-CXw4-Ts7S1tjJh0hbH6jfrDuTblsaMI5-iEjf3fRKbed7N77igNS6KZgJqRvo6Lut3X6G-I1JprgdmuB7_EV-tqaLeHbQOfl3d_v35iF7er5_vLl-yiyv2ZQJlcqrBQBTYBiUrKxrRC5bqzg3tZTMomlQSVW0diFEiUwUFahaCqWauuJzcrnPHYN_W2OcdO-ixa4zA_p11OkBkCJ9f07KPWiDjzFgq8fg-lRZA9O7XfVK73fVu101gE6SbOeH_PWix-bLdBgyARcHwERrujaYwbr4xUnFVcV54q72HKY1Ng6DjtbhYLFxAe2kG---b_IBu_KY8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68017600</pqid></control><display><type>article</type><title>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</title><source>ScienceDirect Journals</source><creator>Kurabayashi, Takumi ; Suzuki, Mina ; Fujita, Kazuyuki ; Murakawa, Haruo ; Hasegawa, Isao ; Tanaka, Kenichi</creator><creatorcontrib>Kurabayashi, Takumi ; Suzuki, Mina ; Fujita, Kazuyuki ; Murakawa, Haruo ; Hasegawa, Isao ; Tanaka, Kenichi</creatorcontrib><description>To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS).
Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100
mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed.
For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120
min, the area under the curve (AUC) and blood insulin levels at 120
min in the non-responder group (
n
=
25) were significantly higher than those in the responder group (
n
=
34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120
mg/dl for the blood glucose level at 120
min and 9000 for the blood glucose
×
insulin level at 120
min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived (
n
=
9) and non-conceived groups (
n
=
21).
The levels of blood glucose and blood glucose
×
insulin at 120
min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2005.11.005</identifier><identifier>PMID: 16337728</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>75-g OGTT ; Administration, Oral ; Adult ; Anovulation ; Area Under Curve ; Biological and medical sciences ; Blood Glucose ; Clomiphene ; Clomiphene - administration & dosage ; Clomiphene - pharmacology ; Female ; Female genital diseases ; Fertility Agents, Female - administration & dosage ; Fertility Agents, Female - pharmacology ; Gynecology. Andrology. Obstetrics ; Humans ; Insulin - blood ; Insulin resistance ; Medical sciences ; Non tumoral diseases ; Ovulation - drug effects ; Ovulation Induction ; Polycystic ovary syndrome ; Polycystic Ovary Syndrome - blood ; Predictive Value of Tests ; Prospective Studies ; ROC Curve</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 2006-06, Vol.126 (2), p.201-205</ispartof><rights>2005 Elsevier Ireland Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</citedby><cites>FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17838533$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16337728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kurabayashi, Takumi</creatorcontrib><creatorcontrib>Suzuki, Mina</creatorcontrib><creatorcontrib>Fujita, Kazuyuki</creatorcontrib><creatorcontrib>Murakawa, Haruo</creatorcontrib><creatorcontrib>Hasegawa, Isao</creatorcontrib><creatorcontrib>Tanaka, Kenichi</creatorcontrib><title>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS).
Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100
mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed.
For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120
min, the area under the curve (AUC) and blood insulin levels at 120
min in the non-responder group (
n
=
25) were significantly higher than those in the responder group (
n
=
34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120
mg/dl for the blood glucose level at 120
min and 9000 for the blood glucose
×
insulin level at 120
min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived (
n
=
9) and non-conceived groups (
n
=
21).
The levels of blood glucose and blood glucose
×
insulin at 120
min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.</description><subject>75-g OGTT</subject><subject>Administration, Oral</subject><subject>Adult</subject><subject>Anovulation</subject><subject>Area Under Curve</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose</subject><subject>Clomiphene</subject><subject>Clomiphene - administration & dosage</subject><subject>Clomiphene - pharmacology</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Fertility Agents, Female - administration & dosage</subject><subject>Fertility Agents, Female - pharmacology</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Insulin - blood</subject><subject>Insulin resistance</subject><subject>Medical sciences</subject><subject>Non tumoral diseases</subject><subject>Ovulation - drug effects</subject><subject>Ovulation Induction</subject><subject>Polycystic ovary syndrome</subject><subject>Polycystic Ovary Syndrome - blood</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>ROC Curve</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P4zAYhK0VKyhd_sEK-QK3ZP3Gie1ckBDiS0KCw-51Ldd5U1wlcbDTov57XFqJG76MLD0zHg8hv4HlwED8WeW48suwyAvGqhwgT_KDzEDJIpOiKo_IjHEGWQFQnZDTGFcsHc7rY3ICgnMpCzUj_1-CXw4-Ts7S1tjJh0hbH6jfrDuTblsaMI5-iEjf3fRKbed7N77igNS6KZgJqRvo6Lut3X6G-I1JprgdmuB7_EV-tqaLeHbQOfl3d_v35iF7er5_vLl-yiyv2ZQJlcqrBQBTYBiUrKxrRC5bqzg3tZTMomlQSVW0diFEiUwUFahaCqWauuJzcrnPHYN_W2OcdO-ixa4zA_p11OkBkCJ9f07KPWiDjzFgq8fg-lRZA9O7XfVK73fVu101gE6SbOeH_PWix-bLdBgyARcHwERrujaYwbr4xUnFVcV54q72HKY1Ng6DjtbhYLFxAe2kG---b_IBu_KY8A</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Kurabayashi, Takumi</creator><creator>Suzuki, Mina</creator><creator>Fujita, Kazuyuki</creator><creator>Murakawa, Haruo</creator><creator>Hasegawa, Isao</creator><creator>Tanaka, Kenichi</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060601</creationdate><title>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</title><author>Kurabayashi, Takumi ; Suzuki, Mina ; Fujita, Kazuyuki ; Murakawa, Haruo ; Hasegawa, Isao ; Tanaka, Kenichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>75-g OGTT</topic><topic>Administration, Oral</topic><topic>Adult</topic><topic>Anovulation</topic><topic>Area Under Curve</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose</topic><topic>Clomiphene</topic><topic>Clomiphene - administration & dosage</topic><topic>Clomiphene - pharmacology</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Fertility Agents, Female - administration & dosage</topic><topic>Fertility Agents, Female - pharmacology</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Insulin - blood</topic><topic>Insulin resistance</topic><topic>Medical sciences</topic><topic>Non tumoral diseases</topic><topic>Ovulation - drug effects</topic><topic>Ovulation Induction</topic><topic>Polycystic ovary syndrome</topic><topic>Polycystic Ovary Syndrome - blood</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>ROC Curve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurabayashi, Takumi</creatorcontrib><creatorcontrib>Suzuki, Mina</creatorcontrib><creatorcontrib>Fujita, Kazuyuki</creatorcontrib><creatorcontrib>Murakawa, Haruo</creatorcontrib><creatorcontrib>Hasegawa, Isao</creatorcontrib><creatorcontrib>Tanaka, Kenichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurabayashi, Takumi</au><au>Suzuki, Mina</au><au>Fujita, Kazuyuki</au><au>Murakawa, Haruo</au><au>Hasegawa, Isao</au><au>Tanaka, Kenichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>126</volume><issue>2</issue><spage>201</spage><epage>205</epage><pages>201-205</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>To evaluate prospectively the prognostic factors for ovulatory responses following clomiphene citrate (CC) administration in polycystic ovary syndrome (PCOS).
Fifty-nine infertile patients with a diagnosis of PCOS were recruited. Ovulation was induced using 100
mg/day CC administered daily from days 5 to 9 of the cycle. Endocrine and metabolic parameters between responder and non-responder groups were analyzed.
For a 75-g fasting glucose load (75-g OGTT), blood glucose levels at 60 and 120
min, the area under the curve (AUC) and blood insulin levels at 120
min in the non-responder group (
n
=
25) were significantly higher than those in the responder group (
n
=
34), although the measurements of fasting blood glucose and insulin were not significantly different between the two groups. In the receiver operating characteristic curves, the most appropriate cutoff point was 120
mg/dl for the blood glucose level at 120
min and 9000 for the blood glucose
×
insulin level at 120
min. There were no significant differences in the clinical characteristics or in the endocrine and metabolic parameters between conceived (
n
=
9) and non-conceived groups (
n
=
21).
The levels of blood glucose and blood glucose
×
insulin at 120
min after 75-g OGTT could be good biochemical markers of CC resistance in PCOS. No predictors of conception following CC therapy were identified by this study.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>16337728</pmid><doi>10.1016/j.ejogrb.2005.11.005</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-2115 |
ispartof | European journal of obstetrics & gynecology and reproductive biology, 2006-06, Vol.126 (2), p.201-205 |
issn | 0301-2115 1872-7654 |
language | eng |
recordid | cdi_proquest_miscellaneous_68017600 |
source | ScienceDirect Journals |
subjects | 75-g OGTT Administration, Oral Adult Anovulation Area Under Curve Biological and medical sciences Blood Glucose Clomiphene Clomiphene - administration & dosage Clomiphene - pharmacology Female Female genital diseases Fertility Agents, Female - administration & dosage Fertility Agents, Female - pharmacology Gynecology. Andrology. Obstetrics Humans Insulin - blood Insulin resistance Medical sciences Non tumoral diseases Ovulation - drug effects Ovulation Induction Polycystic ovary syndrome Polycystic Ovary Syndrome - blood Predictive Value of Tests Prospective Studies ROC Curve |
title | Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A03%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20factors%20for%20ovulatory%20response%20with%20clomiphene%20citrate%20in%20polycystic%20ovary%20syndrome&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Kurabayashi,%20Takumi&rft.date=2006-06-01&rft.volume=126&rft.issue=2&rft.spage=201&rft.epage=205&rft.pages=201-205&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/j.ejogrb.2005.11.005&rft_dat=%3Cproquest_cross%3E68017600%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-680058b11081a0140499ee37fc833a9770ceade8782fcb664e06251897688d953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68017600&rft_id=info:pmid/16337728&rfr_iscdi=true |